HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chul Gu Kim Selected Research

Endothelial Growth Factors

7/2017Effect of Epiretinal Membranes on Antivascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
11/2013Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chul Gu Kim Research Topics

Disease

25Polypoidal Choroidal Vasculopathy
11/2023 - 04/2012
23Macular Degeneration (Age-Related Maculopathy)
11/2023 - 01/2013
18Hemorrhage
02/2023 - 04/2012
5Macular Edema
06/2018 - 09/2007
4Choroidal Neovascularization
01/2022 - 10/2013
4Vitreous Hemorrhage
01/2020 - 04/2012
4Polyps
08/2016 - 06/2012
3Atrophy
01/2023 - 08/2019
3Retinal Detachment (Retinal Detachments)
12/2021 - 10/2013
3Cataract (Cataracts)
06/2018 - 10/2014
2Disease Progression
01/2020 - 01/2016
2Cicatrix (Scar)
01/2020 - 11/2018
2Retinal Telangiectasis
01/2019 - 08/2016
2Retinal Vein Occlusion
06/2018 - 01/2015
2Diabetic Retinopathy (Retinopathy, Diabetic)
06/2018 - 01/2016
1Inflammation (Inflammations)
11/2023
1Retinal Hemorrhage
02/2023
1Retinal Arterial Macroaneurysm
01/2021
1Aneurysm (Aneurysms)
01/2019
1Glaucoma
06/2018
1Intraoperative Complications
06/2018
1Retinal Neovascularization
08/2017
1Epiretinal Membrane (Epiretinal Membranes)
07/2017
1Central Serous Chorioretinopathy
01/2016
1Geographic Atrophy
02/2015
1Hearing Loss (Hearing Impairment)
10/2013
1Susac Syndrome
10/2013
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
10/2013
1Cysts
10/2013
1Scotoma (Scintillating Scotoma)
01/2013
1Hemangioma (Angioma)
09/2007
1Capillary Hemangioma
09/2007

Drug/Important Bio-Agent (IBA)

20Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 09/2013
16Retinaldehyde (Retinal)IBA
02/2023 - 09/2007
15Ranibizumab (Lucentis)FDA Link
11/2021 - 04/2012
11afliberceptIBA
11/2023 - 01/2016
7Bevacizumab (Avastin)FDA Link
01/2021 - 06/2012
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2017 - 10/2013
2Endothelial Growth FactorsIBA
07/2017 - 11/2013
2Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2015 - 09/2007
2Fluorescein (Funduscein)FDA LinkGeneric
10/2013 - 10/2013
1brolucizumabIBA
11/2023
1Retinal Pigments (Pigments, Visual)IBA
01/2023
1Ophthalmic Solutions (Eye Drops)IBA
06/2018
1Therapeutic UsesIBA
03/2013
1Verteporfin (Visudyne)FDA Link
09/2007

Therapy/Procedure

15Injections
11/2023 - 06/2012
12Therapeutics
01/2021 - 03/2013
5Vitrectomy
01/2020 - 04/2012
4Intravitreal Injections
11/2023 - 06/2012
4Aftercare (After-Treatment)
10/2022 - 01/2016
4Lasers (Laser)
01/2019 - 01/2013
3Light Coagulation
01/2019 - 01/2016
1Phacoemulsification
06/2018
1Intraocular Lenses (Intraocular Lens)
10/2014
1Photochemotherapy (Photodynamic Therapy)
09/2007